Bertolotti; Anne

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bertolotti; Anne.The latest application filed is for "inhibitors and their uses".

Company Profile

4.9.12

Bertolotti; Anne - Cambridge GB
BERTOLOTTI; ANNE - PARIS FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for selecting phosphatase selective and non-selective phosphatase inhibitors Grant 11,364,211 - Bertolotti , et al. June 21, 2	2022-06-21
Inhibitors and their uses Grant 11,337,941 - Bertolotti , et al. May 24, 2	2022-05-24
Inhibitors and their uses Grant 11,331,286 - Bertolotti , et al. May 17, 2	2022-05-17
Inhibitors and their uses Grant 11,154,519 - Bertolotti , et al. October 26, 2	2021-10-26
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Grant 10,954,198 - Guedat , et al. March 23, 2	2021-03-23
Inhibitors And Their Uses App 20200297668 - BERTOLOTTI; Anne ; et al.	2020-09-24
Inhibitors And Their Uses App 20200197337 - BERTOLOTTI; Anne ; et al.	2020-06-25
Assay For Screening Modulators Of Holophosphatase Activity App 20200199647 - BERTOLOTTI; Anne ; et al.	2020-06-25
Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases App 20200095210 - Guedat; Philippe ; et al.	2020-03-26
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Grant 10,526,297 - Guedat , et al. J	2020-01-07
Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases App 20180354914 - Guedat; Philippe ; et al.	2018-12-13
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Grant 10,100,020 - Guedat , et al. October 16, 2	2018-10-16
Methods For Selecting Phosphatase Selective And Non-selective Phosphatase Inhibitors App 20180125801 - BERTOLOTTI; Anne ; et al.	2018-05-10
Inhibitors And Their Uses App 20180111896 - BERTOLOTTI; Anne ; et al.	2018-04-26
Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases App 20170247344 - Guedat; Philippe ; et al.	2017-08-31
Benzylideneguanidine derivatives and therapeutic use for the treatment of protein misfolding diseases Grant 9,682,943 - Guedat , et al. June 20, 2	2017-06-20
Benzylideneguanidine Derivatives and Therapeutic Use for the Treatment of Protein Misfolding Diseases App 20160046589 - Guedat; Philippe ; et al.	2016-02-18
Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases Grant 7,932,422 - Bertolotti , et al. April 26, 2	2011-04-26
Screening Molecules With Anti-prion Activity: Kits, Methods And Screened Molecules App 20110092483 - BLONDEL; MARC ; et al.	2011-04-21
Use of chlorine guanabenz derivatives for treating polyglutamine expansion associated diseases App 20100036166 - Bertolotti; Anne ; et al.	2010-02-11
Screening molecules with anti-prion activity: kits, methods and screened molecules App 20070031821 - Blondel; Marc ; et al.	2007-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.